​

Cartesian Therapeutics Ownership | Who Owns Cartesian Therapeutics?

OverviewForecastRevenueFinancialsChart

Cartesian Therapeutics Ownership Summary

Cartesian Therapeutics is owned by 4.30% institutional investors, 59.29% insiders, and 36.41% retail investors. Fidelity Select Biotechnology is the top mutual fund, with 2.96% of its assets in Cartesian Therapeutics shares.

RNAC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCartesian Therapeutics4.30%59.29%36.41%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024666.45%6,666,026-2.94%421.92%4528.57%8-11.11%
Sep 30, 2024625.08%6,868,068109.92%499.52%35-37.50%9200.00%
Jun 30, 2024591375.00%3,271,748176274.56%2-561300.00%3-
Mar 31, 20244-1,855---4---
Sep 30, 20231-1,200-------

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Select Biotechnology766.75K2.96%-
Fidelity Growth Compy Commingled Pl S462.41K1.78%600.00
HBM Healthcare Investments AG Ord415.23K1.60%2.87K
Fidelity Select Health Care368.99K1.42%-
Fidelity Growth Company Fund341.04K1.32%-
Vanguard Total Stock Mkt Idx Inv279.83K1.08%37.13K
iShares Russell 2000 ETF269.26K1.04%-2.31K
Fidelity Advisor Health Care I230.25K0.89%-
Fidelity Advisor Biotechnology I167.95K0.66%167.95K
Vanguard Institutional Extnd Mkt Idx Tr139.31K0.54%-

Recent Insider Transactions

DateNameRoleActivityValue
Apr 09, 2025SPRINGER TIMOTHY A Buy$308.48
Apr 11, 2025SPRINGER TIMOTHY A Buy$69.07K
Apr 10, 2025SPRINGER TIMOTHY A Buy$6.65K
Apr 10, 2025SPRINGER TIMOTHY A Buy$83.12K
Apr 09, 2025SPRINGER TIMOTHY A Buy$69.21K

Insider Transactions Trends

DateBuySell
2025 Q210-
2025 Q1612
2024 Q42017
2024 Q32-
2024 Q2--

RNAC Ownership FAQ

Who Owns Cartesian Therapeutics?

Cartesian Therapeutics shareholders are primarily institutional investors at 4.30%, followed by 59.29% insiders and 36.41% retail investors. The average institutional ownership in Cartesian Therapeutics's industry, Biotech Stocks , is 68.48%, which Cartesian Therapeutics falls below.

Does Blackrock own Cartesian Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cartesian Therapeutics.

Who is the top mutual fund holder of Cartesian Therapeutics shares?

Fidelity Select Biotechnology is the top mutual fund holder of Cartesian Therapeutics shares, with 2.96% of its total shares outstanding invested in 766.75K Cartesian Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools